133 related articles for article (PubMed ID: 25453818)
21. On the discovery of new potent human farnesyltransferase inhibitors: emerging pyroglutamic derivatives.
Homerin G; Lipka E; Rigo B; Farce A; Dubois J; Ghinet A
Org Biomol Chem; 2017 Oct; 15(38):8110-8118. PubMed ID: 28905970
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives.
Jørgensen AS; Jacobsen P; Christiansen LB; Bury PS; Kanstrup A; Thorpe SM; Naerum L; Wassermann K
Bioorg Med Chem Lett; 2000 Oct; 10(20):2383-6. PubMed ID: 11055361
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors.
Baciu-Atudosie L; Ghinet A; Farce A; Dubois J; Belei D; Bîcu E
Bioorg Med Chem Lett; 2012 Nov; 22(22):6896-902. PubMed ID: 23036952
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological evaluation of 5-(4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl)benzonitrile derivatives as xanthine oxidase inhibitors.
Zhang TJ; Li SY; Zhang Y; Wu QX; Meng FH
Chem Biol Drug Des; 2018 Feb; 91(2):526-533. PubMed ID: 28950055
[TBL] [Abstract][Full Text] [Related]
25. Molecular modeling studies and anti-TB activity of trisubstituted indolizine analogues; molecular docking and dynamic inputs.
Khedr MA; Pillay M; Chandrashekharappa S; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Mlisana K; Odhav B; Venugopala KN
J Biomol Struct Dyn; 2018 Jun; 36(8):2163-2178. PubMed ID: 28657441
[TBL] [Abstract][Full Text] [Related]
26. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.
Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E
Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.
Gilleron P; Wlodarczyk N; Houssin R; Farce A; Laconde G; Goossens JF; Lemoine A; Pommery N; Hénichart JP; Millet R
Bioorg Med Chem Lett; 2007 Oct; 17(19):5465-71. PubMed ID: 17827015
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro study of benzofuran hydrazone derivatives as novel alpha-amylase inhibitor.
Taha M; Shah SAA; Imran S; Afifi M; Chigurupati S; Selvaraj M; Rahim F; Ullah H; Zaman K; Vijayabalan S
Bioorg Chem; 2017 Dec; 75():78-85. PubMed ID: 28918064
[TBL] [Abstract][Full Text] [Related]
29. 3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors.
Weide T; Arve L; Prinz H; Waldmann H; Kessler H
Bioorg Med Chem Lett; 2006 Jan; 16(1):59-63. PubMed ID: 16236508
[TBL] [Abstract][Full Text] [Related]
30. Benzoflavones as cholesterol esterase inhibitors: Synthesis, biological evaluation and docking studies.
Singh H; Singh JV; Gupta MK; Singh P; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Feb; 27(4):850-854. PubMed ID: 28117203
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of a new type of non steroidal human aromatase inhibitors.
Sonnet P; Guillon J; Enguehard C; Dallemagne P; Bureau R; Rault S Auvray P; Moslemi S; Sourdiane P; Galopin S; Séralini GE
Bioorg Med Chem Lett; 1998 May; 8(9):1041-4. PubMed ID: 9871704
[TBL] [Abstract][Full Text] [Related]
32. vHTS and 3D-QSAR for the Identification of Novel Phyto-inhibitors of Farnesyltransferase: Validation of Ascorbic Acid inhibition of Farnesyltransferase in an Animal Model of Breast Cancer.
Samuel Metibemu D
Drug Res (Stuttg); 2021 Jul; 71(6):341-347. PubMed ID: 33862663
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B
ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.
Endo S; Hu D; Suyama M; Matsunaga T; Sugimoto K; Matsuya Y; El-Kabbani O; Kuwata K; Hara A; Kitade Y; Toyooka N
Bioorg Med Chem; 2013 Nov; 21(21):6378-84. PubMed ID: 24071447
[TBL] [Abstract][Full Text] [Related]
35. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
[TBL] [Abstract][Full Text] [Related]
36. The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents.
Shen Y; Qiang S; Ma S
Mini Rev Med Chem; 2015; 15(10):837-57. PubMed ID: 25963569
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
Shen YM; Lv PC; Chen W; Liu PG; Zhang MZ; Zhu HL
Eur J Med Chem; 2010 Jul; 45(7):3184-90. PubMed ID: 20304535
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, alkaline phosphatase inhibition studies and molecular docking of novel derivatives of 4-quinolones.
Miliutina M; Ejaz SA; Khan SU; Iaroshenko VO; Villinger A; Iqbal J; Langer P
Eur J Med Chem; 2017 Jan; 126():408-420. PubMed ID: 27907877
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological evaluation and molecular docking of N-phenyl thiosemicarbazones as urease inhibitors.
Hameed A; Khan KM; Zehra ST; Ahmed R; Shafiq Z; Bakht SM; Yaqub M; Hussain M; de la Vega de León A; Furtmann N; Bajorath J; Shad HA; Tahir MN; Iqbal J
Bioorg Chem; 2015 Aug; 61():51-7. PubMed ID: 26119990
[TBL] [Abstract][Full Text] [Related]
40. A Rational Design, Synthesis, Biological Evaluation and Structure--Activity Relationship Study of Novel Inhibitors against Cyanobacterial Fructose-1,6-bisphosphate Aldolase.
Han X; Zhu X; Zhu S; Wei L; Hong Z; Guo L; Chen H; Chi B; Liu Y; Feng L; Ren Y; Wan J
J Chem Inf Model; 2016 Jan; 56(1):73-81. PubMed ID: 26669534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
